NASDAQ:ARQT
Arcutis Biotherapeutics Inc Stock News
$8.63
-0.710 (-7.60%)
At Close: Jun 14, 2024
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be
Kimberly Lathroum Joins Arcutis as Vice President of Marketing
12:30pm, Monday, 23'rd Mar 2020
WESTLAKE VILLAGE, Calif., March 23, 2020 -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
FDA requests study amendment to allow inclusion of children ages 2 to 11 years in the DERMIS-1 and DERMIS-2 trialsStrong safety profile supported population expansion in pivotal.
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz
Heather Rowe Armstrong Joins Arcutis as Vice President of Investor Relations and Corporate Communications
01:30pm, Thursday, 05'th Mar 2020
WESTLAKE VILLAGE, Calif., March 05, 2020 -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing.
WESTLAKE VILLAGE, Calif., March 03, 2020 -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing.
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
02:36pm, Wednesday, 26'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 25) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) (Cowen
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
Stocks To Watch: JPMorgan, Virgin Galactic, Peloton Put To The Test
01:26pm, Saturday, 22'nd Feb 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Arcutis to Present at the Cowen 40th Annual Health Care Conference
01:30pm, Wednesday, 19'th Feb 2020
WESTLAKE VILLAGE, Calif., Feb. 19, 2020 -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing.
Activist Investors Make Moves in Fiesta Restaurant, Chipotle Stock
01:00am, Saturday, 15'th Feb 2020
Arex Capital Management bought more Fiesta stock in late January. Pershing Square trimmed its investment in Chipotle Mexican Grill.
Arcutis Announces Enrollment of First Patient in Topical Roflumilast Cream Phase 3 Open Label Extension Study in Plaque Psoriasis
01:30pm, Thursday, 13'th Feb 2020
Topical Roflumilast Cream (ARQ-151) Potential “Best in Class” Topical PDE4 inhibitorRoflumilast Cream Potentially Only Topical PDE4 inhibitor for PsoriasisOpen Label Extension.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
